Your browser is no longer supported. Please, upgrade your browser.
EPIX [NASD]
ESSA Pharma Inc.
Index- P/E- EPS (ttm)-1.02 Insider Own2.50% Shs Outstand36.48M Perf Week-1.24%
Market Cap1.14B Forward P/E- EPS next Y-1.08 Insider Trans6.25% Shs Float32.73M Perf Month12.28%
Income-25.40M PEG- EPS next Q-0.23 Inst Own67.20% Short Float0.83% Perf Quarter3.82%
Sales- P/S- EPS this Y30.90% Inst Trans11.27% Short Ratio0.90 Perf Half Y362.36%
Book/sh5.63 P/B5.21 EPS next Y- ROA- Target Price- Perf Year527.35%
Cash/sh5.38 P/C5.46 EPS next 5Y- ROE- 52W Range4.36 - 32.69 Perf YTD146.10%
Dividend- P/FCF- EPS past 5Y39.20% ROI- 52W High-10.19% Beta1.66
Dividend %- Quick Ratio65.80 Sales past 5Y- Gross Margin- 52W Low573.39% ATR1.89
Employees11 Current Ratio65.80 Sales Q/Q- Oper. Margin- RSI (14)53.03 Volatility6.58% 7.33%
OptionableNo Debt/Eq0.00 EPS Q/Q20.90% Profit Margin- Rel Volume0.78 Prev Close27.15
ShortableYes LT Debt/Eq0.00 EarningsMay 06 AMC Payout- Avg Volume300.55K Price29.36
Recom- SMA203.23% SMA501.19% SMA20093.56% Volume235,598 Change8.14%
Mar-04-21Initiated Piper Sandler Overweight $50
Jan-11-21Reiterated H.C. Wainwright Buy $10 → $17
Nov-02-20Initiated Jefferies Buy $17
Oct-25-19Initiated Oppenheimer Outperform $8
May-10-21 10:59AM  
May-06-21 07:01AM  
07:01AM  
Apr-28-21 07:00AM  
07:00AM  
Apr-14-21 07:00AM  
07:00AM  
Apr-12-21 10:50AM  
Apr-10-21 08:30AM  
08:30AM  
Mar-26-21 04:05PM  
04:05PM  
Mar-04-21 11:32AM  
11:32AM  
Mar-02-21 08:00AM  
Feb-25-21 06:33PM  
04:30PM  
04:30PM  
07:00AM  
Feb-22-21 11:48AM  
11:48AM  
Feb-17-21 10:47PM  
Feb-16-21 04:01PM  
08:30AM  
Feb-12-21 04:40AM  
Feb-11-21 10:38AM  
08:02AM  
08:02AM  
07:00AM  
07:00AM  
Feb-05-21 04:53PM  
Jan-13-21 07:00AM  
07:00AM  
Jan-08-21 02:50PM  
Dec-17-20 06:27AM  
Dec-15-20 07:50PM  
05:01PM  
05:01PM  
Dec-08-20 09:14AM  
Nov-25-20 07:00AM  
Nov-13-20 12:58PM  
Nov-10-20 07:00AM  
Oct-26-20 05:01PM  
Oct-24-20 07:18PM  
Oct-19-20 07:00AM  
07:00AM  
Sep-21-20 07:00AM  
07:00AM  
Sep-17-20 05:05PM  
Sep-14-20 07:00AM  
Sep-10-20 07:00AM  
Aug-12-20 09:22AM  
Aug-07-20 06:16AM  
Aug-06-20 08:00PM  
Jul-31-20 10:16AM  
Jul-28-20 09:18PM  
04:01PM  
Jul-17-20 09:37AM  
Jul-15-20 07:00AM  
Jun-22-20 07:30AM  
07:30AM  
Jun-04-20 06:25PM  
May-27-20 07:00AM  
07:00AM  
05:32AM  
May-18-20 08:13AM  
May-15-20 07:30AM  
May-12-20 07:25AM  
May-07-20 05:05PM  
05:05PM  
May-01-20 07:54AM  
Apr-30-20 05:45PM  
05:45PM  
Apr-13-20 06:08PM  
06:08PM  
Apr-02-20 05:45AM  
Mar-31-20 07:00AM  
07:00AM  
Mar-24-20 04:00PM  
Mar-19-20 09:18AM  
Feb-27-20 07:51PM  
Feb-18-20 06:10AM  
Feb-13-20 05:48PM  
05:48PM  
Feb-10-20 06:15PM  
Dec-30-19 06:15AM  
Dec-22-19 06:41PM  
Dec-19-19 05:15PM  
Dec-12-19 11:35AM  
Dec-03-19 11:00AM  
Nov-11-19 09:00AM  
Oct-30-19 06:00AM  
06:00AM  
Oct-28-19 07:30AM  
Oct-18-19 04:15PM  
04:15PM  
Oct-11-19 08:15AM  
Oct-07-19 02:04PM  
02:04PM  
Sep-28-19 07:29AM  
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BERGER FRANKLIN MDirectorFeb 22Buy27.0057,0001,539,000957,244Mar 04 06:47 PM
BERGER FRANKLIN MDirectorDec 03Option Exercise3.6442,207153,701900,244Jan 11 04:42 PM